Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Rhea-AI Summary

Enovis Corporation (NYSE: ENOV), a medical technology growth company, will host a conference call and webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. ET. The company will release its earnings report earlier that morning.

Investors can access the live webcast through Enovis' website investor section, and those wishing to participate in the call can dial (833) 685-0901. A presentation and replay of the call will be available on the company's website following the event.

News Market Reaction – ENOV

+2.36%

1 alert

+2.36% News Effect

On the day this news was published, ENOV gained 2.36%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901. A replay of the call will also be available on the Enovis website later that day.

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares at ir.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

FAQ

When will Enovis (NYSE: ENOV) report Q2 2025 earnings?

Enovis will report Q2 2025 earnings on Thursday, August 7th, 2025, with a press release in the morning followed by a conference call at 8:30 a.m. ET.

How can investors access the Enovis Q2 2025 earnings call?

Investors can access the call by dialing (833) 685-0901 or watching the live webcast through the 'Investors' section of Enovis' website at www.enovis.com.

Will there be a replay available of the Enovis Q2 2025 earnings call?

Yes, a replay of the earnings call will be available on the Enovis website later that same day.

What materials will be available for Enovis' Q2 2025 earnings call?

Enovis will provide an earnings press release in the morning before the call and a presentation that can be accessed from the 'Investors' section of their website.